• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1992 Fiscal Year Final Research Report Summary

Inhibitors of cytotoxic T cell activities produced by cultured tumor cells.

Research Project

Project/Area Number 03454466
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field 外科・放射線系歯学
Research InstitutionHIROSHIMA UNIVERSITY

Principal Investigator

TAKADA Kazuaki  Hiroshima Univ. Sch of Dent., Professor, 歯学部, 教授 (30029970)

Co-Investigator(Kenkyū-buntansha) OKAMOTO Tetsuzi  Hiroshima Univ. Dental Hospital, Assistant Professor, 歯学部・附属病院, 講師 (00169153)
Project Period (FY) 1991 – 1992
KeywordsPatients with malignant tumor / Cellular-immune response / Interleukin-2 / Lymphokine-activated killer cells / Serum-free medium / Insulin / Transforming growth factor-beta / Heparin-binding factors
Research Abstract

It has been reported that patients with malignant tumors have a defective cellularimmune status. We have speculated that this defect was resulted from the production of soluble immuno-suppressive factors produced by tumor cells.
We have established serum-free culture system to induce highly cytotoxic lymphokine activated killer (LAK)cells. Using this system, we have studied several growth factors, hormons and medium conditioned by several tumor cells on the growth and cytotoxic activities of LAK cells. Following results were obtained.
1. The LAK cells induced in RD medium supplemented with interleukin-2, human transferrin, 2-mercaptoethanol, 2-aminoethanol and sodium selenite had 3 to 4 times higher cytotoxic activities against tumor cells than the LAK cells in human serum supplemented medium.
2. Insulin or insulin like growth factor-I(IGF-I) which has been produced by many tumor cells as an autocrine or a paracrine growth factor inhibited cytotoxic activities of LAK cells.
3. Transforming growth factor-beta (TGF-beta) inhibited both of the growth and cytotoxic activities of LAK cells.
4. The medium conditioned by cultured squamous carcinoma cells (SCC) and malignant melanoma cells(MM) derived from oral region inhibited both of the growth and cytotoxic activities of LAK cells.
5. Physical and chemical analysis revealed that the suppressive activities of SCC were heat- and acid-resistant but those of MM were heat- and acid-labile. These results suggest that the activities of SCC were different from those of MM.
6. We have fractionated SCC derived activities by heparin-sepharose affinity chromatography. It has been revealed that the fractions which were eluted with 0.9-1.2M NaCl exhibited significant activities which were different from TGF-beta and insulin.

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] 谷 亮治: "無血清培地を用いたlymphokine activated Killer細胞の誘導" 日本口腔外科学会雑誌. 37. 779-787 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岡本 哲治: "ガンの免疫療法の新しい展開:LAK細胞およびTILを用いた養子免疫療法" 広島大学歯科雑誌. 23. 360-361 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Dianging Wu: "Membrane-Baund Transforming Growth Factor-α as an Autocrine Factor for A431 Human Epidermoid carcinoma" Oncogene. (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshinau Myoker: "Uascular Endothelial cell Grawth Factor(VEGF) prodnied by A431 Human Epiderinotd carcinama Cells and identijicatian of VEGF Fmembrane binding site" Proc.Nat1.Acad.Su.USA. 88. 5819-5823 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Dianging Wu: "Characterization and Uolecular Clonig of a Binding protein for Heparin-Binging Growth Faetor" J.Biol.Chem.266. 16778-16785 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 岡本 哲治: "細胞成長因子partIII inoitroからinviuoへの展望" 日本組織培養学会編, (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] J.D.Sato: "Cell Culture Methods For call Biolagy chaptesVI" ARL press,NY., (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Dianging Wu: "Membrane-bound transforming growth factora as an autocrine growth factor for A431 human epidermoid carcinoma" Oncogene. (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] J.D.Sato: "Cell Culture Methods For Cell Biology, Specific celln types and their requirements, inpress" Cell Culture Methods for cell biology,ARL press,NY. (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshinari Myoken: "Vascular endothelial cell growth factor (VEGF) produced by A431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites." Proc Natl Acad. Sci. USA. Vol.88. 5819-5823 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Dianging Wu: "Characterization and molecular cloning of a binding protein for heparin-binding growth factor" J. Biol. Chem. Vol.266. 16778-16785 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tetsuji Okamoto: "Vascular endothelial cell growth factor, in press" Cellular growth factor, from in vitro to in vivo, Japanese J. of Tissue culture association. (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ryouji Tani: "Induction of lymphokine activated killer cells in serum-free medium" Jpn. J. Oral Maxillofac. Surg. Vol.37. 779-787 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tetsuji Okamoto: "New era of cancer immunotherapy, Adoptive immunotherapy by LAK and TIL cells." J. of Hiroshima Dental School. vol.23. 360-361 (1991)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1994-03-24  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi